These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 5616009

  • 1. [Effects of new vasoactive drug, 3(beta-diethylamino-ethyl)-4-methyl-7-(carbethoxy-methoxy)-2-oxy-1,2-chromen HC1 (Intensain) on the coronary circulation in dogs].
    Campus S, Pandolfo G, Dessy P, Gagna C, Uslenghi E.
    Minerva Cardioangiol; 1967 Nov; 15(11):722-4. PubMed ID: 5616009
    [No Abstract] [Full Text] [Related]

  • 2. Systemic and coronary hemodynamic effects of 3-(beta-diethylamino-ethyl)-4-methyl-7-carbethoxy-methoxy-2-oxo-(1,2-chromene)-hydrochloride (Intensain, A-27053).
    Rowe GG, Terry W, Stenlund RR, Thomsen JH, Querimit AS.
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):99-103. PubMed ID: 5353477
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A new vasoactive substance regulating the metabolic response of the coronaries.
    Szentiványi M, Juhász-Nagy A, Debreczeni L.
    Acta Physiol Acad Sci Hung; 1967 Mar; 31(1):9-32. PubMed ID: 6079690
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of a K+ATP channel opener, lemakalim, on systemic, coronary and regional vascular dynamics in conscious dogs: comparison with nifedipine, adenosine, nitroglycerin and acetylcholine.
    Shen YT, Vatner SF.
    J Pharmacol Exp Ther; 1993 May; 265(2):1026-37. PubMed ID: 8496801
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Studies on nifedipine, a coronary vasodilator agent with rapid sublingual effects].
    Raff WK, Kosche F, Lochner W.
    Arzneimittelforschung; 1972 Jan; 22(1):33-9. PubMed ID: 5066995
    [No Abstract] [Full Text] [Related]

  • 12. [Effect of a beta-adrenergic-blocking agent (propranolol) on systemic and coronary hemodynamics in dogs].
    Feruglio FS, Campus S, Pandolfo G, Dessy P, Gagna C, Uslenghi E.
    Boll Soc Ital Biol Sper; 1966 Sep 30; 42(18):1209-11. PubMed ID: 5971146
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [The effect of pharmacologic agents coronary circulation in experimental spasms of heart vessels].
    Kareva GF.
    Vestn Akad Med Nauk SSSR; 1963 Sep 30; 18(1):28-32. PubMed ID: 4971961
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The role of NO release in the control of large and small coronary artery tone in conscious dogs.
    La Rochelle CD, Dubois-Randé JL, Richard V, Hittinger L, Giudicelli JF, Berdeaux A.
    J Cardiovasc Pharmacol; 1993 Sep 30; 22 Suppl 7():S17-21. PubMed ID: 7504763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.